Cardiovascular complications of conventional and targeted adjuvant breast cancer therapy-Reference-Cited by-同舟云学术

Cardiovascular complications of conventional and targeted adjuvant breast cancer therapy

Published:2011-06 Issue:6 Volume:22 Page:1250-1258
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Harbeck N.,Ewer M.S.,De Laurentiis M.,Suter T.M.,Ewer S.M.

Funder

The paper is based on the proceedings of a series of medical conferences held in Vienna in October 2008. Both the paper and the conferences were supported by an unrestricted grant from Sanofi-aventis

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/22/6/1250/575518/mdq543.pdf

Reference74 articles.

1. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer;Romond;N Engl J Med,2005

2. Two-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial;Smith;Lancet,2007

3. Trastuzumab after adjuvant chemotherapy in HER-2 positive breast cancer;Piccart-Gebhart;N Engl J Med,2005

4. Effects of screening and adjuvant therapy on mortality from breast cancer;Berry;N Engl J Med,2005

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex difference in human diseases: mechanistic insights and clinical implications;Signal Transduction and Targeted Therapy;2024-09-10

2. Clonal Hematopoiesis in Young Women Treated for Breast Cancer;Clinical Cancer Research;2023-04-28

3. Hazard-based risk grouping effectively stratifying breast cancer patients in post-irradiation long-term heart diseases: a population-based cohort study;Frontiers in Cardiovascular Medicine;2023-04-27

4. Emerging trends and hotspots evolution in cardiotoxicity: A bibliometric and knowledge-Map analysis From 2010 to 2022;Frontiers in Cardiovascular Medicine;2023-03-07

5. Successful Treatment with Low-dose Crizotinib in a Patient with <i>ROS1</i>-rearranged Lung Cancer Who Developed Crizotinib-induced Heart Failure;Internal Medicine;2023-01-15